Pakistan Steps Up Pharmacovigilance
New Guidance Implements More Robust Drug Surveillance
Executive Summary
A new guidance document explains how Pakistan’s revamped pharmacovigilance system will work.
You may also be interested in...
Pakistan Updates Pharmacovigilance Guidance To Factor In New Rules
Revised guidelines on pharmacovigilance follow newly introduced legislation on this front.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.